<DOC>
	<DOCNO>NCT01947595</DOCNO>
	<brief_summary>The purpose prospective randomize multicenter intervention study determine whether prevention Diabetes intensify lifestyle intervention superior conventional lifestyle intervention high risk non-Responder subject . Further , intensive phenotyping determine subgroup increase risk diabetes enable individualize prevention therapy type 2 diabetes mellitus .</brief_summary>
	<brief_title>Individualized Lifestyle Intervention Subjects With Prediabetes</brief_title>
	<detailed_description>The study start intensive phenotyping baseline ( initial examination ) determine subject prediabetes . These high risk non-Responder randomized two arm ( intensified v normal lifestyle intervention ) equal number subject ( n=250 ) . The result compare end study . The low risk Responder randomize two arm ( normal vs. lifestyle intervention = control group ) equal number subject ( n=250 ) . After screen baseline 12 month lifestyle intervention start lifestyle intervention group . The different therapy group form describe . The subject intensify lifestyle intervention get 16 consultation , subject normal lifestyle intervention get 8 consultation , subject control group get one consultation learn healthy lifestyle . During whole study continuous supervision physician nutritional adviser subject document nutrition exercise protocol well subjective measurement . At baseline , 24 week follow 1 , 2 3 year later elaborate metabolic characterization subject ( also Responder group ) 75 g venous oral glucose tolerance test ( OGTT ) well analysis distribution body fat confirm MR-Imaging proton magnetic resonance spectroscopy 3 T whole body imager .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Prediabetic State</mesh_term>
	<mesh_term>Glucose Intolerance</mesh_term>
	<criteria>impaired fasting glucose ( IFG ) fast blood glucose 99126 mg/dl and/or impair glucose tolerance ( IGT ) 75 g OGTT 120 minute : 139200 mg/dl current pregnancy breastfeed BMI &gt; 45 kg/m² Diabetes mellitus Typ 1 2 serious disease e.g symptomatic coronary heart disease serious symptomatic malignant disease ( weight loss &gt; 10 % within last 6 month ) severe liver kidney disease ( increase transaminases &gt; 3 time upper limit standardize range , GFR &lt; 50 ml/min/1,73m² ) systemic infection ( CRP &gt; 1 mg/dl ) severe mental illness drug abuse treatment steroid potentially incompliant subject exclusion criterion magnetic resonance tomography kind metal body : cardiac pacemaker prosthetic heart valves metal prosthesis magnetic implant metallic part contraceptive coil metal fragments/ grenade shrapnel fix brace acupuncture needle insulin pump intraport etc . Field strength &gt; 3 Tesla tattoo , permanent makeup person limit thermosensory heighten sensitivity heat person cardiovascular disease rule examination person heighten sensitivity loud noise disease ear use closed whole body scanner : claustrophobia Additional spirometry acute coronary syndrome high cardiac arrhythmia decompensated heart failure acute carditis pulmonary embolism acute deep leg vein thrombosis ( phlebothrombosis ) hyperthyroidism ( TSH ) hypokalemia</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>diabetes mellitus type 2</keyword>
	<keyword>impaired glucose tolerance</keyword>
	<keyword>lifestyle intervention</keyword>
	<keyword>body fat distribution</keyword>
	<keyword>prevention</keyword>
</DOC>